Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing old drugs to fight multidrug resistant cancers
Jelena Dinić, Thomas Efferth, Alfonso T. García‐Sosa, et al.
Drug Resistance Updates (2020) Vol. 52, pp. 100713-100713
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update
Kritika Engle, Gautam Kumar
European Journal of Medicinal Chemistry (2022) Vol. 239, pp. 114542-114542
Closed Access | Times Cited: 119
Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 104
Drug Repurposing: An Effective Tool in Modern Drug Discovery
V. S. Kulkarni, V. Alagarsamy, V. Raja Solomon, et al.
Russian Journal of Bioorganic Chemistry (2023) Vol. 49, Iss. 2, pp. 157-166
Open Access | Times Cited: 91
Hydrolysis, Ligand Exchange, and Redox Properties of Vanadium Compounds: Implications of Solution Transformation on Biological, Therapeutic, and Environmental Applications
Rupam Dinda, Eugenio Garribba, Daniele Sanna, et al.
Chemical Reviews (2025)
Closed Access | Times Cited: 3
Krebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis
Amin Gasmi, Massimiliano Peana, Maria Arshad, et al.
Archives of Toxicology (2021) Vol. 95, Iss. 4, pp. 1161-1178
Closed Access | Times Cited: 59
Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges
Popat Kumbhar, Arehalli S. Manjappa, Rohit Shah, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 1-15
Closed Access | Times Cited: 56
High-dimensional role of AI and machine learning in cancer research
Enrico Capobianco
British Journal of Cancer (2022) Vol. 126, Iss. 4, pp. 523-532
Open Access | Times Cited: 40
Repurposing Antidepressants and Phenothiazine Antipsychotics as Efflux Pump Inhibitors in Cancer and Infectious Diseases
Bálint Rácz, Gabriella Spengler
Antibiotics (2023) Vol. 12, Iss. 1, pp. 137-137
Open Access | Times Cited: 29
Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells
Min Ji Seo, In Young Kim, Dong Min Lee, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Iron nitroprusside as a chemodynamic agent and inducer of ferroptosis for ovarian cancer therapy
Kanwal Asif, Muhammad Adeel, Md. Mahbubur Rahman, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 14, pp. 3124-3135
Open Access | Times Cited: 22
Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and antiinflammatory agents
Xuemei Xu, Zhaojingtao Zhu, Siyu Chen, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 8
Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions
Leilei Fu, Wenke Jin, Jiahui Zhang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 532-557
Open Access | Times Cited: 51
Machine learning, artificial intelligence, and data science breaking into drug design and neglected diseases
José Peña‐Guerrero, Paul Nguewa, Alfonso T. García‐Sosa
Wiley Interdisciplinary Reviews Computational Molecular Science (2021) Vol. 11, Iss. 5
Closed Access | Times Cited: 49
Molecular Modeling Strategies of Cancer Multidrug Resistance
Gözde Yalçın
Drug Resistance Updates (2021) Vol. 59, pp. 100789-100789
Closed Access | Times Cited: 46
Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance
Nirmala Tilija Pun, Chul‐Ho Jeong
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 470-470
Open Access | Times Cited: 45
Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics
Enrique Hernández-Lemus, Mireya Martínez-García
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 42
Quality by design steered development of Niclosamide loaded liposomal thermogel for Melanoma: In vitro and Ex vivo evaluation
Saurabh Shah, Paras Famta, Valencia Fernandes, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2022) Vol. 180, pp. 119-136
Closed Access | Times Cited: 30
Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro , molecular docking, molecular dynamics, and SAR studies
Faten Farouk, Ayman Abo Elmaaty, Ahmed Elkamhawy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment
M. Helena Vasconcelos, Andreia Palmeira, Sofia Martins Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 13, pp. 1171-1195
Closed Access | Times Cited: 18
Repurposing antifungal drugs for cancer therapy
Ningna Weng, Zhe Zhang, Yunhan Tan, et al.
Journal of Advanced Research (2022) Vol. 48, pp. 259-273
Open Access | Times Cited: 27
Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models
Vilma Petrikaitė, Nicola d’Avanzo, Christian Celia, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100956-100956
Closed Access | Times Cited: 15
Network Pharmacology of Adaptogens in the Assessment of Their Pleiotropic Therapeutic Activity
Alexander Panossian, Thomas Efferth
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 22
Exploring therapeutic potential of Rutin by investigating its cyclin-dependent kinase 6 inhibitory activity and binding affinity
Mohd Yousuf, Shama Khan, Afzal Hussain, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130624-130624
Closed Access | Times Cited: 4
Therapeutic Mechanisms of Phenothiazine Drugs: A Mini-Review of Advances in Cancer Treatment and Antibiotic Resistance
Xiangyu Zou, Bai Xie
Deleted Journal (2025) Vol. 24, Iss. 1
Open Access
Drug Repurposing and Virtual Screening
Ruchika Sharma, Sweta Roy, Anoop Kumar
(2025), pp. 399-421
Closed Access
Page 1 - Next Page

Scroll to top